Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Welcome to our press release archive. To learn more about how we work with healthcare and business reporters worldwide, or if you are looking for specific data and expert insights to support a current story, please contact us at [email protected].
With more than 1,600 employees across the globe, the new organization is now one of the world’s largest pharma intelligence solutions providers on the market
New World Preview report finds strong top-line growth as pricing and patent headwinds build
The new organization will help life sciences companies improve strategic decision-making and accelerate the mission of smoothing access to therapy from pipeline to…
LONDON, BOSTON, TOKYO (June 21, 2021) – Evaluate, a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, is pleased to…
Evaluate, a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, is delighted to announce that it has completed the…
The top 600 biopharma firms added $487 billion in market capitalisation in 2020, according to the Evaluate Vantage Pharma, Biotech & Medtech 2020 in Review report,…
Inova and the Biotechnology Innovation Organization (BIO), in partnership with Evaluate announce the second annual series of Virtual Partnering events focused on critical…
COVID-19 will continue to be a defining issue for pharma and biotech companies in 2021, but overall the sector will start the year from a position of strength, according…
Game-changing offering leverages the power of machine learning to fill critical information gaps in the early-stage pharmaceutical pipeline.
Evaluate Ltd., a leading provider of commercial intelligence and predictive analytics to the pharmaceutical industry, today announces that it has secured additional…
“Pharma, Biotech and Medtech Half-Year Review 2020” analyses the market performance and deal landscape for the first half of 2020, focusing on the impact of COVID-19
The impact of COVID-19 has so far wiped $7.85bn off forecasts for biopharma sales in 2020, with the top 15 companies bearing 60% of that loss, according to the…
COVID-19 Virtual Partnering is a unique and free-to-attend virtual event taking place on 20 April – 06 May. The initiative is backed by a consortium of biotech clusters…